SG10201402285XA - Burst drug release compositions - Google Patents
Burst drug release compositionsInfo
- Publication number
- SG10201402285XA SG10201402285XA SG10201402285XA SG10201402285XA SG10201402285XA SG 10201402285X A SG10201402285X A SG 10201402285XA SG 10201402285X A SG10201402285X A SG 10201402285XA SG 10201402285X A SG10201402285X A SG 10201402285XA SG 10201402285X A SG10201402285X A SG 10201402285XA
- Authority
- SG
- Singapore
- Prior art keywords
- drug release
- release compositions
- burst drug
- burst
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17794309P | 2009-05-13 | 2009-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201402285XA true SG10201402285XA (en) | 2014-08-28 |
Family
ID=42647324
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201402285XA SG10201402285XA (en) | 2009-05-13 | 2010-05-13 | Burst drug release compositions |
| SG2011081312A SG175892A1 (en) | 2009-05-13 | 2010-05-13 | Burst drug release compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011081312A SG175892A1 (en) | 2009-05-13 | 2010-05-13 | Burst drug release compositions |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20100311839A1 (en) |
| EP (2) | EP2429501B1 (en) |
| JP (2) | JP5740396B2 (en) |
| KR (1) | KR101471240B1 (en) |
| CN (2) | CN102458375A (en) |
| AR (1) | AR076907A1 (en) |
| AU (1) | AU2010248979A1 (en) |
| BR (1) | BRPI1010987B8 (en) |
| CA (1) | CA2761795C (en) |
| CO (1) | CO6390100A2 (en) |
| ES (1) | ES2707275T3 (en) |
| HU (2) | HUE053202T2 (en) |
| IL (1) | IL216186B (en) |
| MX (1) | MX336065B (en) |
| NZ (1) | NZ596275A (en) |
| PL (1) | PL2429501T3 (en) |
| PT (1) | PT2429501T (en) |
| RU (2) | RU2541807C2 (en) |
| SG (2) | SG10201402285XA (en) |
| TR (1) | TR201900220T4 (en) |
| TW (1) | TWI478733B (en) |
| WO (1) | WO2010132635A1 (en) |
| ZA (1) | ZA201109084B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
| BR112018071908A2 (en) * | 2016-04-26 | 2019-02-05 | Lts Lohmann Therapie Systeme Ag | film-like administration method for transmucosal release of antidiabetic peptides and method for producing same |
| CN117017932A (en) * | 2023-08-24 | 2023-11-10 | 浙江和沐康医药科技有限公司 | Sulindac tablet composition and preparation method and application thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4983398A (en) * | 1987-12-21 | 1991-01-08 | Forest Laboratories, Inc. | Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
| JPH01319416A (en) * | 1988-06-21 | 1989-12-25 | Dai Ichi Kogyo Seiyaku Co Ltd | Tablet binder capable of controlling release |
| JPH05255125A (en) * | 1992-02-29 | 1993-10-05 | Upjohn Co:The | Sustained release preparation and its preparation |
| HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
| GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| US6632451B2 (en) * | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
| AR034517A1 (en) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | PHARMACEUTICAL FORMULATION |
| US20040101494A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US20060068009A1 (en) * | 2004-09-30 | 2006-03-30 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
| US20070077297A1 (en) * | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
| US7749537B2 (en) * | 2006-12-04 | 2010-07-06 | Scolr Pharma, Inc. | Method of forming a tablet |
-
2010
- 2010-05-12 TW TW099115137A patent/TWI478733B/en active
- 2010-05-12 AR ARP100101650A patent/AR076907A1/en not_active Application Discontinuation
- 2010-05-13 TR TR2019/00220T patent/TR201900220T4/en unknown
- 2010-05-13 JP JP2012510998A patent/JP5740396B2/en active Active
- 2010-05-13 HU HUE18199791A patent/HUE053202T2/en unknown
- 2010-05-13 MX MX2011012045A patent/MX336065B/en unknown
- 2010-05-13 PT PT10720087T patent/PT2429501T/en unknown
- 2010-05-13 CN CN2010800301511A patent/CN102458375A/en active Pending
- 2010-05-13 HU HUE10720087A patent/HUE042857T2/en unknown
- 2010-05-13 SG SG10201402285XA patent/SG10201402285XA/en unknown
- 2010-05-13 AU AU2010248979A patent/AU2010248979A1/en not_active Abandoned
- 2010-05-13 CA CA2761795A patent/CA2761795C/en active Active
- 2010-05-13 WO PCT/US2010/034660 patent/WO2010132635A1/en active Application Filing
- 2010-05-13 RU RU2011145436/15A patent/RU2541807C2/en active
- 2010-05-13 NZ NZ596275A patent/NZ596275A/en unknown
- 2010-05-13 CN CN201710268720.XA patent/CN107028909A/en active Pending
- 2010-05-13 KR KR1020117029675A patent/KR101471240B1/en active IP Right Grant
- 2010-05-13 US US12/779,130 patent/US20100311839A1/en not_active Abandoned
- 2010-05-13 PL PL10720087T patent/PL2429501T3/en unknown
- 2010-05-13 ES ES10720087T patent/ES2707275T3/en active Active
- 2010-05-13 BR BRPI1010987A patent/BRPI1010987B8/en active IP Right Grant
- 2010-05-13 SG SG2011081312A patent/SG175892A1/en unknown
- 2010-05-13 EP EP10720087.5A patent/EP2429501B1/en active Active
- 2010-05-13 EP EP18199791.7A patent/EP3459530B1/en active Active
-
2011
- 2011-11-07 IL IL21618611A patent/IL216186B/en active IP Right Grant
- 2011-11-15 CO CO11155173A patent/CO6390100A2/en not_active Application Discontinuation
- 2011-12-09 ZA ZA2011/09084A patent/ZA201109084B/en unknown
-
2012
- 2012-10-26 US US13/661,890 patent/US20130116327A1/en not_active Abandoned
-
2014
- 2014-11-24 RU RU2014146936A patent/RU2014146936A/en not_active Application Discontinuation
-
2015
- 2015-04-27 JP JP2015090130A patent/JP2015155452A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181755T1 (en) | Immediate release tablet formulations | |
| HK1231408A1 (en) | Pharmaceutical composition | |
| HK1218881A1 (en) | Pharmaceutical compositions | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| EP2398469A4 (en) | Controlled release compositions comprising anti-cholinergic drugs | |
| EP2379077A4 (en) | Pharmaceutical composition | |
| ZA201109084B (en) | Burst drug release compositions | |
| IL219018A0 (en) | Pharmaceutical compositions | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| GB0914989D0 (en) | Drug release formulations | |
| GB0901241D0 (en) | Pharmaceutical compositions | |
| GB201104464D0 (en) | Fragrance release burst | |
| GB201016615D0 (en) | Drug release composition |